ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 147 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2024. The put-call ratio across all filers is 1.09 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $36,002 | -97.3% | 12,163 | -91.1% | 0.00% | -100.0% |
| Q1 2022 | $1,335,000 | -86.1% | 136,910 | -79.6% | 0.02% | -83.9% |
| Q4 2021 | $9,590,000 | +20.6% | 670,639 | +69.0% | 0.14% | +5.4% |
| Q3 2021 | $7,952,000 | -8.9% | 396,816 | 0.0% | 0.13% | -20.2% |
| Q2 2021 | $8,730,000 | +0.9% | 396,816 | +55.7% | 0.16% | -15.1% |
| Q1 2021 | $8,656,000 | -50.1% | 254,902 | -40.9% | 0.19% | -58.3% |
| Q4 2020 | $17,347,000 | – | 431,087 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 7,305,761 | $104,472,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $53,961,000 | 89.75% |
| Gruss & Co., LLC | 426,966 | $6,106,000 | 16.39% |
| SB Management Ltd | 9,817,190 | $140,386,000 | 13.88% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $58,703,000 | 5.51% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $45,346,000 | 4.36% |
| Intellectus Partners, LLC | 1,192,379 | $17,051,000 | 4.35% |
| Founders Fund Growth Management, LLC | 407,017 | $5,820,000 | 3.28% |
| ArchPoint Investors | 461,289 | $6,596,000 | 1.96% |
| Belmont Capital, LLC | 150,000 | $2,145,000 | 1.68% |